Clinical Investigator / Institution Eligibility

NCI Formulary Proposals will only be accepted from NCI funded main-member ETCTN and NCTN institutions in the United States and their investigators.

Clinical trial site participants are limited to NCI funded main-member ETCTN and NCTN institutions in the United States and their investigators.

Clinical protocols are to be conducted as single institution studies.

NCI funded main-member ETCTN and NCTN institutions must be in good-standing with an Acceptable or Acceptable Needs Follow-up Rating on their most recent NCI audit.

NCI funded main-member ETCTN and NCTN institutions and their investigators must have resources and experience to support activities as an IND sponsor.

NCI funded main-member ETCTN and NCTN institutions and their investigators must have funding to support clinical trial activities and provide evidence of such funding at the time of proposal submission. Clinical trial activities for these investigator-initiated trials cannot be conducted using ETCTN or NCTN funding.

All participating investigators and sub-investigator must be registered with the NCI and maintain an active registration status.